柳药集团: 广西柳药集团股份有限公司监事会与董事会审计委员会关于公司2025年股票期权激励计划相关事项的核查意见

Core Viewpoint - The company has conducted a necessary review of the 2025 stock option incentive plan and has determined that it meets the legal and regulatory requirements for implementation [1][5][6] Group 1: Eligibility and Compliance - The company is qualified to implement the incentive plan as it does not fall under any disqualifying conditions outlined in relevant laws and regulations [1][2] - The incentive plan's targets include company directors, senior management, and core personnel, excluding independent directors and major shareholders [3][5] Group 2: Implementation Process - The company will publicly disclose the names and positions of the incentive plan participants for a minimum of 10 days before the shareholders' meeting [3][5] - The board's remuneration and assessment committee will provide a review of the participant list and public feedback five days prior to the shareholders' meeting [3][5] Group 3: Benefits and Strategic Alignment - The incentive plan is designed to enhance the motivation and creativity of the management team, contributing to the long-term healthy development of the company [5][6] - The assessment management measures are aligned with legal requirements and the company's actual situation, ensuring the effective implementation of the incentive plan [5]